Christopher Ryan Sullivan's Net Worth
-$12.4 Thousand
Who is Christopher Ryan Sullivan?
Christopher Ryan Sullivan does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Avalo Therapeutics, Inc..
SEC CIK
Christopher Ryan Sullivan's CIK is 0001810417
Past Insider Trading and Trends
2022 was Christopher Ryan Sullivan's most active year for acquiring shares with 3 total transactions. Christopher Ryan Sullivan's most active month to acquire stocks was the month of February. 2020 saw Christopher Ryan Sullivan paying a total of $18,335.62 for 8,049 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Avalo Therapeutics, Inc. (AVTX) Snapshot price: $7.25
Chief Financial OfficerChristopher Ryan Sullivan owns 1,262 units of Common Stock which is worth $9,149.50. From 2020 to 2024 Christopher Ryan Sullivan acquired a total of 9,515 shares in Avalo Therapeutics, Inc. at a cost of $21,582.59.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 13
| |||
Form 4
| +68.04% | 511 |
$3.42 | $1,747.62 | 1.26K |
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
| +11.86% | 955 |
$1.57 | $1,499.35 | 9K |
Dec 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
| +172.48% | 5.09K |
$2.28 | $11,606.41 | 8.05K |
Dec 10
| |||
Form 4
|
∞
| 2.95K |
$2.28 | $6,729.21 | 2.95K |
Jun 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||